Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells

Neoplasia

Volumn 4, Issue 3, 2002, Pages 204-217

  Oh, J S ^a   Kucab, J E ^b,c   Bushel, P R ^a   Martin, K ^a   Bennett, L ^a   Collins, J ^c   Diaugustine, R P ^a   Barrett, J C ^d   Afshari, C A ^a   Dunn, S E ^b,c  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AKT; Breast cancer; Insulin like growth factor 1 receptor; Microarray; Transcription factors

Indexed keywords

ANGIOGENIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; FAS LIGAND; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; NUCLEAR PROTEIN; PROTEIN C FOS; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; UROKINASE; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RISK; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; REGULATORY MECHANISM; RNA BINDING; UNINDEXED SEQUENCE;

EID: 0036097379     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj/neo/7900229     Document Type: Article

References (67)

1. Insulin-like growth factor-1 in relation to premenopausal ductal carcinoma in situ of the breast
2. Circulating insulin-like growth factor-1 and the risk of breast cancer
3. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF-1) and IGF-binding protein-3
4. Plasma levels of insulin-like growth factor-1 and lung cancer risk: A case-control analysis
5. Plasma insulin-like growth factor-1 and prostate cancer risk: A prospective study
6. Reduced growth of human breast cancer xenographs in hosts homozygous for the lit mutation
7. Dietary restriction reduces insulin-like growth factor-1 levels which modulates apoptosis, cell proliferation, and tumor progression in p53 deficient mice
8. Overexpression of the human insulin-like growth factor-1 receptor promotes ligand dependent neoplastic transformation
9. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 receptor are nontumorigenic and induce regression of wild-type tumors
10. Antisense mediated reduction in insulin-like growth factor I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma
11. Interference of the IGF system as a strategy to inhibit breast cancer growth
12. Mutant IGF-1 receptors as dominant negatives for growth and transformation
13. A dominant negative mutant of the insulin-like growth factor-1 receptor inhibits the adhesion, invasion, and metastasis of breast cancer
14. Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor receptor in malignant astrocytomas
15. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin linked kinase
16. Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B
17. AKT signaling: Linking membrane events to life and death decisions
18. Role of translocation in the activation and function of protein kinase B
19. Translocation of AKT/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to growth factors
20. Regulation of neuronal survival by the serine-threonine protein kinase AKT
21. Upregulation of urokinase type plasminogen activator by insulin-like growth factor-1 depends upon phosphotidyl inositol-3 kinase and map kinase
22. AKT takes center stage in angiogenesis signaling
23. Modulation of hypoxia-inducible factor 1 alpha expression by the epidermal growth after phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
24. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1 alpha/ARNT
25. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
26. CREB is a regulatory target for protein kinase AKT/PKB
27. Characterization of a CREB gain of function mutant with constitutive transcriptional activity in vivo
28. Hypoxia induces phosphorylation of the cyclic AMP response element-binding protein by a novel signaling mechanism
29. Insulin-like growth factor-1 mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. Involvement of p38 mitogen-activated protein kinase-mediated pathway
30. Hypoxia activates AKT and induces phosphorylation of GSK-3 in PC12 cells
31. AKT promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor
32. Direct control of the forkhead transcription factor AFX by protein kinase B
33. Molecular portraits of human breast tumors
34. Microarrays and toxicology: The advent of toxicogenomics
35. Exploring the metabolic and genetic control of gene expression on a genomic scale
36. Ratio-based decisions and the quantitative analysis of cDNA microarray images
37. The Microarray Project System for gene expression experiment information and data validation
38. Cluster analysis and display of genome-wide expression patterns
39. The insulin-like growth factor-1 elevates urokinase-type plasminogen activator-1 in human breast cancer cells: A new avenue for Breast Cancer Therapy
40. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-1 human breast carcinoma cells
41. The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site
42. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity
43. Rat CYP1A1 negative regulatory element: Biological activity and interaction with a protein from liver and hepatoma cells
44. Myc represses the growth arrest gene GADD45
45. Myc represses transcription of the growth arrest gene gas1
46. Identification of connective tissue growth factor as a target of WT1 transcriptional regulation
47. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer
48. Expression of calcium-binding protein S100A2 in breast lesions
49. Expression of hemidesmosomes and component proteins is lost by invasive breast cancer cells
50. Plasma insulin-like growth factor-1 (IGF-1), IGF-binding protein 3 and mammographic density
51. Growth factors and stromal matrix proteins associated with mammographic density
52. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
53. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
54. Vascular endothelial growth factor (VEGF) and is receptors
55. Functional analysis of CpG methylation in the BRCA1 promoter region
56. Regulation of the catalase gene promoter by Spl, CCAAT-recognizing factors, and a WR1/Egr-related factor in hydrogen peroxide-resistant HP100 cells
57. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells
58. Genomic structure of the promoters of the human estrogen-alpha gene demonstrate changes in chromatin structure induced by AP2gamma
59. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition
60. Structure of the human glutathione S-transferase pl gene
61. Regulation of transcription of the glutathione S-transferase P1 gene by methylation of the minimal promoter in human leukemia cells
62. Methylation -mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells
63. Molecular cloning and expression analysis of human glycogen synthase-3 alpha kinase
64. Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance
65. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance gene-1
66. Cell-cycle regulation of the DNA topoisomerase II alpha promoter is mediated by proximal CCAAT boxes: Possible involvement of acetylation
67. Cloning and characterization of the 5-flanking regions for the human topoisomerase III gene